Biopsija prostate (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Biopsija prostate" in Serbian language version.

refsWebsite

Global rank Serbian rank

11nih.gov

4^th place

8^th place

8doi.org

2^nd place

4^th place

5archive.org

6^th place

5^th place

archive.org

Purohit, R. S.; Shinohara K; Meng MV; Carroll PR (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .
Merrill, R. M.; Stephenson RA. (2000). „Trends in Mortality Rates in Patients with Prostate Cancer During the Era of Prostate Specific Antigen Screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0. .
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X. .
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .

doi.org

Purohit, R. S.; Shinohara K; Meng MV; Carroll PR (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .
Merrill, R. M.; Stephenson RA. (2000). „Trends in Mortality Rates in Patients with Prostate Cancer During the Era of Prostate Specific Antigen Screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Siegel, R.; Naishadham, D.; Jemal, A. (2012). „Cancer statistics, 2012”. CA Cancer J Clin. 62 (1): 10—29. PMID 22237781. doi:10.3322/caac.20138.
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0. .
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X. .
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .
Pokorny, Morgan R.; De Rooij, Maarten; Duncan, Earl; Schröder, Fritz H.; Parkinson, Robert; Barentsz, Jelle O.; Thompson, Leslie C. (јул 2014). „"Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies"”. European Urology. 66 (1): 22—29. PMID 24666839. doi:10.1016/j.eururo.2014.03.002. .
Raheem, O. A.; Casey, R. G.; Galvin, D. J.; et al. (2012). „Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience”. Korean Journal of Urology. 53 (4): 234—9. PMC 3332133 . PMID 22536465. doi:10.4111/kju.2012.53.4.234. .

nih.gov

ncbi.nlm.nih.gov

Purohit, R. S.; Shinohara K; Meng MV; Carroll PR (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .
Soulié M, Salomon L (2013). „Screening for prostate cancer: why, how?”. Rev Prat. 63: 469—71. PMID 23682467. , 473, 475
Merrill, R. M.; Stephenson RA. (2000). „Trends in Mortality Rates in Patients with Prostate Cancer During the Era of Prostate Specific Antigen Screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Siegel, R.; Naishadham, D.; Jemal, A. (2012). „Cancer statistics, 2012”. CA Cancer J Clin. 62 (1): 10—29. PMID 22237781. doi:10.3322/caac.20138.
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0. .
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X. .
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2. .
Soulié M, Salomon L (2013). „Screening for prostate cancer: why, how?”. Rev Prat. 63: 469—71. PMID 23682467. , 473, 475.
Shariat, S. F.; Roehrborn CG. (2008). „Using biopsy to detect prostate cancer”. Rev Urol. 10: 262—80. PMID 19145270.
Pokorny, Morgan R.; De Rooij, Maarten; Duncan, Earl; Schröder, Fritz H.; Parkinson, Robert; Barentsz, Jelle O.; Thompson, Leslie C. (јул 2014). „"Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies"”. European Urology. 66 (1): 22—29. PMID 24666839. doi:10.1016/j.eururo.2014.03.002. .
Raheem, O. A.; Casey, R. G.; Galvin, D. J.; et al. (2012). „Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience”. Korean Journal of Urology. 53 (4): 234—9. PMC 3332133 . PMID 22536465. doi:10.4111/kju.2012.53.4.234. .